LifeTech Scientific (HKG:1302) said an aortic arch stent graft system obtained official registration approval from China's National Medical Products Administration, a Thursday Hong Kong bourse filing said.
The firm has independent intellectual property rights for the stent graft system, which was jointly developed by the company, the National Centre for Cardiovascular Diseases, Professor Shu Chang of Fuwai Hospital, and the Chinese Academy of Medical Sciences.